Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older — United states, 2016

Morbidity and Mortality Weekly Report

Volumn 65, Issue 4, 2016, Pages 88-89

  Kim, David K ^a   Bridges, Carolyn B ^a   Harriman, Kathleen H ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b California Department of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ADULT; ADVISORY COMMITTEE; FEMALE; HUMAN; IMMUNIZATION; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; STANDARDS; UNITED STATES;

ADULT; ADVISORY COMMITTEES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; UNITED STATES; VACCINES;

EID: 84959531754     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6504a5     Document Type: Article

References (8)

1. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015;64:944–7. http://dx.doi.org/10.15585/mmwr.mm6434a4.
2. Bennett NM, Whitney CG, Moore M, Pilishvili T, Dooling KL. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816–9.
3. Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015;64:608–12.
4. MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015;64:1171–6. http://dx.doi.org/10.15585/mmwr.mm6441a3.
5. Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015;64:300–4.
6. Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 influenza season. MMWR Morb Mortal Wkly Rep 2015;64:818–25. http://dx.doi.org/10.15585/mmwr.mm6430a3.
7. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 1997;46(RR-08).
8. Kim DK, Bridges CB, Harriman KH; Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2016. Ann Intern Med 2016;164:184-94. http://dx.doi.org/10.7326/M15-3005.